Page last updated: 2024-11-06

bis(2-(succinimidooxycarbonyloxy)ethyl)sulfone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Bis(2-(succinimidooxycarbonyloxy)ethyl)sulfone (BSES) is a cross-linking reagent used in various applications. It is a bifunctional reagent containing two N-hydroxysuccinimide (NHS) esters linked by a sulfone group. This structure allows BSES to react with primary amines in proteins, peptides, and other molecules, forming stable amide bonds.

BSES has been utilized for various purposes, including:

- Cross-linking proteins: BSES can be used to cross-link proteins, resulting in the formation of stable protein complexes. This can be useful for studying protein-protein interactions, immobilizing enzymes, and creating protein-based biomaterials.
- Modification of antibodies: BSES can be used to modify antibodies, allowing them to be conjugated with various molecules, such as enzymes, fluorescent dyes, or drugs. This enhances the functionality of antibodies and enables their application in diverse fields like diagnostics and therapy.
- Synthesis of bioconjugates: BSES is employed in the synthesis of bioconjugates by linking therapeutic agents or diagnostic probes to proteins or other biomolecules. This approach enables the development of targeted drug delivery systems and advanced diagnostic tools.

BSES is studied due to its unique properties as a cross-linking reagent. Its stability, high reactivity, and water-solubility make it suitable for various applications in biochemistry, biotechnology, and pharmaceuticals.

The synthesis of BSES typically involves reacting succinic anhydride with N-hydroxysuccinimide to form NHS ester. Subsequently, the NHS ester reacts with 2-hydroxyethyl sulfone to yield BSES.

Overall, BSES is a versatile reagent employed in numerous applications related to protein modification, antibody engineering, and bioconjugate synthesis. Its importance lies in its ability to form stable covalent bonds with proteins, enabling the development of novel therapeutic, diagnostic, and research tools.'
```

bis(2-(succinimidooxycarbonyloxy)ethyl)sulfone: bifunctional reagent for intramolecular crosslinking of insulin; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93771
SCHEMBL ID43777
MeSH IDM0058189

Synonyms (29)

Synonym
nsc338309
57683-72-4
nsc-338309
bsocoes
bis[2-(n-succinimidyl-oxycarbonyloxy)ethyl] sulfone, >=97.0% (chn)
bis(2-(succinimidooxycarbonyloxy)ethyl)sulfone
(2,5-dioxopyrrolidin-1-yl) 2-[2-(2,5-dioxopyrrolidin-1-yl)oxycarbonyloxyethylsulfonyl]ethyl carbonate
bis[2-(succinimidooxycarbonyloxy)ethyl]sulfone
nsc 338309
einecs 260-904-8
disuccinimido sulphonylbis(ethylenecarbonate)
1,1'-[sulfonylbis(2,1-ethanediyloxycarbonyloxy)]bis-2,5-pyrrolidinedione
bis[2-(n-succinimidyl-oxycarbonyloxy)ethyl] sulfone
bis[2-(succinimidooxycarbonyloxy)ethyl] sulfone
FT-0623114
AKOS015915672
SCHEMBL43777
bis-2-(succinimidoxycarbonyloxy)ethyl sulfone
DTXSID20206385
bis[2-(succinimidooxycarbonyloxy)-ethyl]sulfone
bis(2,5-dioxopyrrolidin-1-yl) (sulfonylbis(ethane-2,1-diyl)) bis(carbonate)
CS-0181242
bis[2-(n-succinimidyl-oxycarbonyloxy)ethyl] sulfon
mfcd00047123
bis(2,5-dioxopyrrolidin-1-yl) 2,2'-sulfonylbis(ethane-2,1-diyl) dicarbonate
H28VHA5U7J
2,5-pyrrolidinedione, 1,1'-[sulfonylbis(2,1-ethanediyloxycarbonyloxy)]bis-
bis[2-(n-succinimidyloxycarbonyloxy)ethyl]sulfone
carbonic acid, c,c'-(sulfonyldi-2,1-ethanediyl) c,c'-bis(2,5-dioxo-1-pyrrolidinyl) ester
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (61.54)18.7374
1990's4 (30.77)18.2507
2000's1 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.74 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.38 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]